BJDX
Price
$1.18
Change
-$0.07 (-5.60%)
Updated
Dec 2 closing price
Capitalization
2.27M
Intraday BUY SELL Signals
MBOT
Price
$2.38
Change
+$0.17 (+7.69%)
Updated
Dec 3, 02:23 PM (EDT)
Capitalization
151.78M
84 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BJDX vs MBOT

Header iconBJDX vs MBOT Comparison
Open Charts BJDX vs MBOTBanner chart's image
Bluejay Diagnostics
Price$1.18
Change-$0.07 (-5.60%)
Volume$90.88K
Capitalization2.27M
Microbot Medical
Price$2.38
Change+$0.17 (+7.69%)
Volume$7.1K
Capitalization151.78M
BJDX vs MBOT Comparison Chart in %
BJDX
Daily Signal:
Gain/Loss:
MBOT
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BJDX vs. MBOT commentary
Dec 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BJDX is a Hold and MBOT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Dec 03, 2025
Stock price -- (BJDX: $1.18 vs. MBOT: $2.21)
Brand notoriety: BJDX and MBOT are both not notable
BJDX represents the Medical/Nursing Services, while MBOT is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BJDX: 3% vs. MBOT: 67%
Market capitalization -- BJDX: $2.27M vs. MBOT: $151.78M
BJDX [@Medical/Nursing Services] is valued at $2.27M. MBOT’s [@Pharmaceuticals: Other] market capitalization is $151.78M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $222.59B to $0. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $201.13B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.77B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $11.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BJDX’s FA Score shows that 1 FA rating(s) are green whileMBOT’s FA Score has 0 green FA rating(s).

  • BJDX’s FA Score: 1 green, 4 red.
  • MBOT’s FA Score: 0 green, 5 red.
According to our system of comparison, BJDX is a better buy in the long-term than MBOT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BJDX’s TA Score shows that 4 TA indicator(s) are bullish while MBOT’s TA Score has 4 bullish TA indicator(s).

  • BJDX’s TA Score: 4 bullish, 4 bearish.
  • MBOT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both BJDX and MBOT are a good buy in the short-term.

Price Growth

BJDX (@Medical/Nursing Services) experienced а -14.49% price change this week, while MBOT (@Pharmaceuticals: Other) price change was +17.55% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.75%. For the same industry, the average monthly price growth was -0.24%, and the average quarterly price growth was +7.07%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -0.14%. For the same industry, the average monthly price growth was +6.50%, and the average quarterly price growth was +2.44%.

Reported Earning Dates

MBOT is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.75% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

@Pharmaceuticals: Other (-0.14% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MBOT($152M) has a higher market cap than BJDX($2.27M). MBOT YTD gains are higher at: 97.321 vs. BJDX (-75.770). BJDX has higher annual earnings (EBITDA): -6.36M vs. MBOT (-13.4M). MBOT has more cash in the bank: 32.7M vs. BJDX (4.44M). MBOT has less debt than BJDX: MBOT (149K) vs BJDX (172K). BJDX (0) and MBOT (0) have equivalent revenues.
BJDXMBOTBJDX / MBOT
Capitalization2.27M152M1%
EBITDA-6.36M-13.4M47%
Gain YTD-75.77097.321-78%
P/E Ratio0.01N/A-
Revenue00-
Total Cash4.44M32.7M14%
Total Debt172K149K115%
FUNDAMENTALS RATINGS
MBOT: Fundamental Ratings
MBOT
OUTLOOK RATING
1..100
23
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
52
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BJDXMBOT
RSI
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 10 days ago
79%
Bullish Trend 6 days ago
74%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
BJDX
Daily Signal:
Gain/Loss:
MBOT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VWDRY8.210.31
+3.92%
Vestas Wind Systems A/S
NNCHY32.250.41
+1.29%
Nissan Chemical Corporation
APTOF1.65N/A
N/A
Aptose Biosciences. Inc.
CRECF0.28N/A
N/A
Critical Elements Lithium Corporation
PIAGF2.08N/A
N/A
Piaggio & C Spa Pontedera

BJDX and

Correlation & Price change

A.I.dvisor tells us that BJDX and CVRX have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BJDX and CVRX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BJDX
1D Price
Change %
BJDX100%
-5.60%
CVRX - BJDX
28%
Poorly correlated
-4.68%
MBOT - BJDX
23%
Poorly correlated
-2.21%
PSNL - BJDX
23%
Poorly correlated
+4.34%
RDNT - BJDX
22%
Poorly correlated
-1.51%
CTSO - BJDX
22%
Poorly correlated
+2.11%
More